The prices were made possible by the Inflation Reduction Act, which granted the health secretary the authority to negotiate on behalf of Medicare.
https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png00https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png2024-08-15 14:45:092024-08-15 14:45:092026 Prices for Drugs That Are Subject to Negotiations
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.